• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MYRX:US

0.1200 USD 0.0049 3.92%

As of 20:10:04 ET on 01/26/2015.

Snapshot for Myrexis Inc (MYRX)

Open: 0.1249 Day's Range: 0.1117 - 0.1249 Volume: 2,150
Previous Close: 0.1249 52wk Range: 0.0700 - 0.2000 1-Yr Rtn: -25.00%

Stock Chart for MYRX

No chart data available.
  • MYRX:US 0.1200
  • 1D
  • 1M
  • 1Y
0.1249
Interactive MYRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.4152
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 4.14
Shares Outstanding (M) 34.48
30 Day Average Volume 53,151
Price/Book (mrq) 3.5576
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 2.8600
Dividend Ex-Date 02/19/2013
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYRX

No data available

Company Profile & Key Executives for MYRX

Myrexis Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing novel small molecule drugs for the treatment of cancer. Myriad's pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures.

Jonathan M CouchmanChairman/President/CEO/CFO
More Company Profile & Key Executives for MYRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil